Suggestive association with ocular phoria at chromosome 6p22

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 1, 2013, Pages 345-352

  Bosten, Jenny M ^a   Hogg, Ruth E ^a,b   Bargary, Gary ^a,c   Goodbourn, Patrick T ^a,d   Lawrance Owen, Adam J ^a   Mollon, John D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c CITY UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ALDH5A1; GWAS; Phoria; SSADH; Strabismus

Indexed keywords

4 AMINOBUTYRIC ACID; SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

ALDH5A1 GENE; ARTICLE; EYE DISEASE; FALSE POSITIVE RESULT; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HETEROPHORIA; HUMAN; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STRABISMUS;

ALDH5A1; GWAS; PHORIA; SSADH; STRABISMUS;

ADOLESCENT; ADULT; CHROMOSOMES, HUMAN, PAIR 6; DNA; DNA MUTATIONAL ANALYSIS; EYE MOVEMENTS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MUTATION; STRABISMUS; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE; YOUNG ADULT;

EID: 84896713727     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12879     Document Type: Article

References (76)

1. Von Noorden G, Campos E. Binocular Vision and Ocular Motility: Theory and Management of Strabismus, Sixth Edition. Maryland Heights: Mosby, Inc.; 2002.
2. Waardenburg P, Franceschetti A, Klein D. Genetics and Ophthalmology Vol. I. Springfield: Charles C Thomas; 1961.
3. Michaelides M, Moore AT. The genetics of strabismus. J Med Genet. 2004;41:641-646.
4. Wilmer JB, Backus BT. Genetic and environmental contributions to strabismus and phoria: evidence from twins. Vision Res. 2009;49:2485-2493.
5. Sanfilippo PG, Hammond CJ, Staffieri SE, et al. Heritability of strabismus: genetic influence is specific to eso-deviation and independent of refractive error. Twin Res Hum Genet. 2012; 15:624-630.
6. Parikh V, Shugart YY, Doheny KF, et al. A strabismus susceptibility locus on chromosome 7p. Proc Natl Acad Sci US A. 2003;100:12283-12288.
7. Shaaban S, Matsuo T, Fujiwara H, et al. Chromosomes 4q28.3 and 7q31.2 as new susceptibility loci for comitant strabismus. Invest Ophthalmol Vis Sci. 2009;50:654-661.
8. Khan A, Shinwari J, Dhaim N, Khalil D, Al Sharif L, Al Tassan N. Potential linkage of different phenotypic forms of childhood strabismus to a recessive susceptibility locus (16p13.12-p12.3). Mol Vis. 2011;17:971-976.
9. Miyake N, Demer J, Shaaban S, et al. Expansion of the CHN1 strabismus phenotype. Invest Ophthalmol Vis Sci. 2011;52: 6321-6328.
10. Engle E. The genetic basis of complex strabismus. Pediatr Res. 2006;59:343-348.
11. Saladin J, Sheedy J. Population study of fixation disparity, heterophoria, and vergence. Am J Optom Physiol Opt. 1978; 55:744-750.
12. Schiffman J, Maeda JA, Hayashi K, et al. Premorbid childhood ocular alignment abnormalities and adult schizophreniaspectrum disorder. Schizophr Res. 2006;81:253-260.
13. Toyota T, Yoshitsugu K, Ebihara M, et al. Association between schizophrenia with ocular misalignment and polyalanine length variation in PMX2B. Hum Mol Genet 2004;13:551-561. GWAS of Phorias
14. Woodhouse JM, Griffiths C, Gedling A. The prevalence of ocular defects and the provision of eye care in adults with learning disabilities living in the community. Ophthalmic Physiol Opt. 2000;20:79-89.
15. Van Splunder J, Stilma JS, Bernsen RMD, Evenhuis HM. Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities. Ophthalmology. 2004;111: 1457-1463.
16. Karadag R, Yagci R, Erdurmus M, Keskin U, Aydin B, Durmus M. Ocular findings in individuals with intellectual disability. Can J Ophthalmol. 2007;42:703-706.
17. Kapp M, von Noorden G, Jenkins R. Strabismus in Williams syndrome. Am J Ophthalmol. 1995;119:355-360.
18. Haugen OH, Høvding G. Strabismus and binocular function in children with Down syndrome. A population-based, longitudinal study. Acta Ophthalmol Scand. 2001;79:133-139.
19. Caputo A, Wagner R, Reynolds D, Guo S, Goel A. Down syndrome: clinical review of ocular features. Clin Pediatr (Phila). 1989;28:355-358.
20. Hiles D, Wallar P, Mcfarlane F. Current concepts in the management of strabismus in children with cerebral palsy. Ann Ophthalmol. 1975;7:789-798.
21. Greaves B, Walker J, Wybar K. Disorders of ocular motility in craniofacial dysostosis. J R Soc Med. 1979;72:21-24.
22. Tay T, Martin F, Rowe N, et al. Visual manifestations of craniofrontonasal dysplasia. J Pediatr Ophthalmol Strabismus. 2007;44:251-254.
23. Netland PA, Scott ML, Boyle JW, Lauderdale JD. Ocular and systemic findings in a survey of aniridia subjects. J AAPOS. 2011;15:562-566.
24. Gardiner P, Joseph M. Eye defects in children with congenital heart lesions: a preliminary study. Dev Med Child Neurol. 1968;10:42-48.
25. Chan T, Bowell R, O'Keefe M, Lanigan B. Ocular manifestations in fetal alcohol syndrome. Br J Ophthalmol. 1991;75:524-526.
26. Strömland K, Hellström A. Fetal alcohol syndrome an ophthalmological and socioeducational prospective study. Pediatrics. 1996;97:845-850.
27. Chew E, Remaley N, Tamboli A, Zhao J, Podgor M, Klebanoff M. Risk factors for esotropia and exotropia. Arch Ophthalmol. 1994;112:1349-1355.
28. Goodbourn PT, Bosten JM, Hogg RE, Bargary G, LawranceOwen AJ, Mollon JD. Do different "magnocellular tasks" probe the same neural substrate? Proc R Soc B Biol Sci. 2012;279: 4263-4271.
29. Lawrance-Owen AJ, Bargary G, Bosten JM, Goodbourn PT, Hogg RE, Mollon JD. Genetic association suggests that SMOC1 mediates between prenatal sex hormones and digit ratio. Hum Genet. 2013;132:415-421.
30. Sulzman JH, Cook EB, Bartlett NR. The validity and reliability of heterophoria scores yielded by three commercial optical devices. J Appl Psychol. 1948;32:56-62.
31. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
32. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38: 904-909.
33. Howie BN, onnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genomewide association studies. PLoS Genet. 2009;5:e1000529.
34. Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda). 2011;1:457-470.
35. Abecasis GR, Altshuler D, Auton A, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073.
36. Ripke S, O'Dushlaine C, Chambert K, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45:1150-1159.
37. Van der Sluis S, Posthuma D, Dolan CV. TATES: efficient multivariate genotype-phenotype analysis for genome-wide association studies. PLoS Genet. 2013;9:e1003235.
38. Blasi P, Boyl PP, Ledda M, et al. Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms. Mol Genet Metab. 2002;76:348-362.
39. Pearl PL, Gibson KM, Acosta MT, et al. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology. 2003;60:1413-1417.
40. Bekri S, Fossoud C, Plaza G, et al. The molecular basis of succinic semialdehyde dehydrogenase deficiency in one family. Mol Genet Metab. 2004;81:347-351.
41. Chambliss KL, Hinson DD, Trettel F, et al. Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria). Am J Hum Genet. 1998;63:399-408.
42. Jung R, Rauch A, Salomons GS, et al. Clinical, cytogenetic and molecular characterization of a patient with combined succinic semialdehyde dehydrogenase deficiency and incomplete WAGR syndrome with obesity. Mol Genet Metab. 2006; 88:256-260.
43. Blasi P, Palmerio F, Caldarola S, et al. Succinic semialdehyde dehydrogenase deficiency: clinical, biochemical and molecular characterization of a new patient with severe phenotype and a novel mutation. Clin Genet. 2006;69:294-296.
44. Akaboshi S, Hogema BM, Novelletto A, et al. Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel diseasecausing mutations in patients with SSADH deficiency. Hum Mutat. 2003;22:442-450.
45. Pearl PL, Novotny EJ, Acosta MT, Jakobs C, Gibson KM. Succinic semialdehyde dehydrogenase deficiency in children and adults. Ann Neurol. 2003;54(suppl 6):S73-S80.
46. Gibson KM, Christensen E, Jakobs C, et al. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-Hydroxybutyric Aciduria): case reports of 23 new patients. Pediatrics. 1997;99:567-574.
47. Johannessen CU. Mechanisms of action of valproate: a commentatory. Neurochem Int. 2000;37:103-110.
48. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci. 2007;64:2090-2103.
49. Clayton-Smith J, Donnai D. Fetal valproate syndrome. J Med Genet. 1995;32:724-727.
50. DiLiberti JH, Farndon PA, Dennis NR, Curry CJR. The fetal valproate syndrome. Am J Med Genet. 1984;19:473-481.
51. Hogema BM, Gupta M, Senephansiri H, et al. Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat Genet. 2001;29:212-216.
52. Gupta M, Polinsky M, Senephansiri H, et al. Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency. Neurobiol Dis. 2004;16: 556-562.
53. Wu Y, Buzzi A, Frantseva M, et al. Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms. Ann Neurol. 2006;59:42-52. GWAS of Phorias
54. Donarum EA, Stephan DA, Larkin K, et al. Expression profiling reveals multiple myelin alterations in murine succinate semialdehyde dehydrogenase deficiency. J Inherit Metab Dis. 2006;29:143-156.
55. Barcelo-Coblijn G, Murphy EJ, Mills K, et al. Lipid abnormalities in succinate semialdehyde dehydrogenase (Aldh5a1-/-) deficient mouse brain provide additional evidence for myelin alterations. Biochim Biophys Acta. 2007;1772:556-562.
56. Nylen K, Velazquez JLP, Likhodii SS, et al. A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype. Exp Neurol. 2008;210:449-457.
57. Thaker G. Early visual processing impairment is associated with ALDH5A1 gene. Biol Psychiatry. 2012;71:16S.
58. Jia P, Wang L, Meltzer HY, Zhao Z. Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res. 2010;122:38-42.
59. Siggberg L, Mustonen A, Schuit R, et al. Familial 6p22.2 duplication associates with mild developmental delay and increased SSADH activity. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:448-453.
60. Pernhorst K, Raabe A, Niehusmann P, et al. Promoter variants determine c-aminobutyric acid homeostasis-related gene transcription in human epileptic hippocampi. J Neuropathol Exp Neurol. 2011;70:1080-1088.
61. Cavalleri GL, Weale ME, Shianna KV, et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol. 2007;6: 970-980.
62. Chabris CF, Hebert BM, Benjamin DJ, et al. Most reported genetic associations with general intelligence are probably false positives. Psychol Sci. 2012;23:1314-1323.
63. Plomin R, Turic DM, Hill L, et al. A functional polymorphism in the succinate-semialdehyde dehydrogenase (aldehyde dehydrogenase 5 family, member A1) gene is associated with cognitive ability. Mol Psychiatry. 2004;9:582-586.
64. De Rango F, Leone O, Dato S, et al. Cognitive functioning and survival in the elderly: the SSADH C538T polymorphism. Ann Hum Genet. 2008;72(pt 5):630-635.
65. Keiner G. New Viewpoints on the Origin of Squint. The Hague: Martinus Nijhoff; 1951.
66. Lang J. A new hypothesis on latent nystagmus and on the congenital squint syndrome. In: van Balen A, Houtman W, eds. Documenta Ophthalmologica Proceedings Series. Vol. 32. Amsterdam: Springer Netherlands, 1982;83-86.
67. Piskacek M, Zotova L, Zsurka G, Schweyen RJ. Conditional knockdown of hMRS2 results in loss of mitochondrial Mg(2{thorn}) uptake and cell death. J Cell Mol Med. 2009;13:693-700.
68. Metz C, Brunner G, Choi-Muira N. Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J. 1994;13:1741-1751.
69. Paracchini S, Thomas A, Castro S, et al. The chromosome 6p22 haplotype associated with dyslexia reduces the expression of KIAA0319, a novel gene involved in neuronal migration. Hum Mol Genet. 2006;15:1659-1666.
70. Szalkowski CE, Fiondella CF, Truong DT, Rosen GD, LoTurco JJ, Fitch RH. The effects of Kiaa0319 knockdown on cortical and subcortical anatomy in male rate. Int J Dev Neurosci. 2013;31: 116-122.
71. Darki F, Peyrard-Janvid M, Matsson H, Kere J, Klingberg T. Three dyslexia susceptibility genes, DYX1C1, DCDC2, and KIAA0319, affect temporo-parietal white matter structure. Biol Psychiatry. 2012;72:671-676.
72. Simons HD, Grisham JD. Binocular anomalies and reading problems. J Am Optom Assoc. 1987;58:578-587.
73. Pestalozzi D. Further observations of dyslexia patients with prism correction [in German]. Klin Monbl Augenheilkd. 1992;200:614-619.
74. Latvala ML, Korhonen TT, Penttinen M, Laippala P. Ophthalmic findings in dyslexic schoolchildren. Br J Ophthalmol. 1994;78: 339-343.
75. Wahlberg-Ramsay M, Nordström M, Salkic J, Brautaset R. Evaluation of aspects of binocular vision in children with dyslexia. Strabismus. 2012;20:139-144.
76. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177-182.